CN116621814A - Fluorescent probe for detecting peroxynitroso anions, preparation method and application thereof - Google Patents
Fluorescent probe for detecting peroxynitroso anions, preparation method and application thereof Download PDFInfo
- Publication number
- CN116621814A CN116621814A CN202310627342.5A CN202310627342A CN116621814A CN 116621814 A CN116621814 A CN 116621814A CN 202310627342 A CN202310627342 A CN 202310627342A CN 116621814 A CN116621814 A CN 116621814A
- Authority
- CN
- China
- Prior art keywords
- probe
- fluorescent probe
- preparation
- reaction
- niml
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 24
- 150000001450 anions Chemical class 0.000 title claims abstract description 9
- 239000000523 sample Substances 0.000 claims abstract description 73
- 230000006907 apoptotic process Effects 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 8
- 230000000694 effects Effects 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 238000006243 chemical reaction Methods 0.000 claims description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 238000003384 imaging method Methods 0.000 claims description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000012043 crude product Substances 0.000 claims description 7
- 238000001953 recrystallisation Methods 0.000 claims description 7
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000012800 visualization Methods 0.000 claims description 6
- FLHJIAFUWHPJRT-UHFFFAOYSA-N 2,3,3-trimethylindole Chemical compound C1=CC=C2C(C)(C)C(C)=NC2=C1 FLHJIAFUWHPJRT-UHFFFAOYSA-N 0.000 claims description 4
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 4
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 4
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 claims description 4
- 231100000135 cytotoxicity Toxicity 0.000 claims description 2
- 230000003013 cytotoxicity Effects 0.000 claims description 2
- 230000003834 intracellular effect Effects 0.000 claims description 2
- 239000012074 organic phase Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 abstract description 12
- 230000004044 response Effects 0.000 abstract description 12
- XJHABGPPCLHLLV-UHFFFAOYSA-N benzo[de]isoquinoline-1,3-dione Chemical compound C1=CC(C(=O)NC2=O)=C3C2=CC=CC3=C1 XJHABGPPCLHLLV-UHFFFAOYSA-N 0.000 abstract description 5
- 230000008859 change Effects 0.000 abstract description 5
- 238000012984 biological imaging Methods 0.000 abstract description 4
- 150000002475 indoles Chemical class 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 230000003595 spectral effect Effects 0.000 abstract description 3
- 125000004193 piperazinyl group Chemical group 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 38
- 238000012360 testing method Methods 0.000 description 26
- 239000000243 solution Substances 0.000 description 22
- 230000005284 excitation Effects 0.000 description 17
- 238000002189 fluorescence spectrum Methods 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 239000011259 mixed solution Substances 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002904 solvent Substances 0.000 description 7
- 238000004448 titration Methods 0.000 description 7
- 102000004157 Hydrolases Human genes 0.000 description 6
- 108090000604 Hydrolases Proteins 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000001506 fluorescence spectroscopy Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 4
- 238000002211 ultraviolet spectrum Methods 0.000 description 4
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000008045 co-localization Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 210000001822 immobilized cell Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- VBXYAKBKJUUJDR-UHFFFAOYSA-N benzaldehyde;hydrate Chemical compound O.O=CC1=CC=CC=C1 VBXYAKBKJUUJDR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000007444 cell Immobilization Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000000839 kinetic spectroscopy Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- CMFNMSMUKZHDEY-UHFFFAOYSA-M peroxynitrite Chemical compound [O-]ON=O CMFNMSMUKZHDEY-UHFFFAOYSA-M 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- -1 superoxide anions Chemical class 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6443—Fluorimetric titration
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention provides a fluorescent probe for detecting peroxynitroso anions, a preparation method and application thereof, wherein the probe is formed by connecting naphthalimide with indole salt through piperazine groups, the naphthalimide is a common fluorophore, and the structural characteristics of the indole salt enable the naphthalimide to have certain affinity with RNA. Spectral results demonstrate that probe NIML has a certain response to ONOO-and that the probe has a significant change in fluorescence signal in a biological imaging experiment with respect to apoptosis. The fluorescence probe NIML provided by the invention can detect the change of the ONOO concentration in a ratio, has low detection limit and short response time, has good response effects on viscosity and RNA, and can effectively detect the apoptosis process.
Description
Technical Field
The invention belongs to the technical field of organic material science, and particularly relates to a fluorescent probe for detecting peroxynitroso anions, a preparation method and application thereof.
Background
Peroxynitrite (ONOO-) is a strong oxidant as active oxygen. It has been found that such strong oxidants are typically generated by coupling nitric oxide with superoxide anions. ONOO-levels are normal and are able to defend against the invasion of some cytotoxins; when ONOO-levels are abnormal, they act as toxic substances, destroying various biomolecules due to their high reactivity, which can cause the destruction of the cell structure and thus the loss of function. Therefore, efficient detection of ONOO-is of great importance.
Cell death comprises three forms: apoptosis, cell necrosis, autophagy. Apoptosis, among other things, is a tightly controlled manner of apoptosis. Apoptosis plays a very important role both physiologically and pathologically. Physiologically, apoptosis is actively involved in various physiological processes in biological systems, such as embryonic development, immune processes, etc.; pathologically, damaged or infected cells are eliminated. This feature becomes one of the approaches to treat cancer: the preparation of a medicament can induce apoptosis to destroy cancer cells. Therefore, monitoring apoptosis is of great importance. Currently, there are several methods for detecting apoptosis. For example, annexin V probes are constructed to target phosphatidylserine on the cell surface so as to monitor apoptosis, but the probes have short shelf life, long detection time and low detection sensitivity.
Therefore, constructing fluorescent probes to detect apoptosis with high sensitivity and fast visualization is a problem to be solved.
Disclosure of Invention
The invention constructs a novel fluorescent probe NIML. The probe is formed by connecting naphthalimide, which is a common fluorophore, with indole salt through piperazine groups, and the structural characteristics of the indole salt enable the naphthalimide to have certain affinity with RNA. Spectral results demonstrate the ability of probe NIML to respond to ONOO-; meanwhile, the probe can have obvious fluorescence signal change in a biological imaging experiment on apoptosis.
The invention discloses a fluorescent probe for detecting peroxynitroso anions, the code of the fluorescent probe is NIML, and the fluorescent probe has the following structure:
the invention also provides a preparation method of the probe NIML, which comprises the following steps:
preparation of intermediate 1: adding 4-bromo-1, 8-naphthalene anhydride and N, N-dimethyl ethylenediamine into ethanol, heating to react, cooling to separate out solid, filtering to obtain intermediate 1 crude product, and recrystallizing with organic solvent to obtain pure intermediate 1;
preparation of intermediate 2: adding piperazine and p-fluorobenzaldehyde into ethylene glycol monomethyl ether for heating reaction, cooling for crystallization, filtering, adding an organic solvent for recrystallization to obtain an intermediate 2;
preparation of intermediate 3: adding the intermediate 1 and the intermediate 2 into a reaction bottle, adding the reaction bottle into ethylene glycol monomethyl ether, heating for reaction, cooling, adding water and an organic solvent, layering, concentrating an organic phase to obtain a crude product of the intermediate 3, and purifying by a silica gel chromatographic column to obtain a pure intermediate 3;
preparation of intermediate 4: adding 2, 3-trimethyl-3H-indole and methyl iodide into a reaction bottle, adding ethanol, heating for reaction for 7-10 hours, cooling for crystallization, filtering and washing to obtain an intermediate 4;
preparation of probe NIML: adding the intermediate 3, the intermediate 4 and the piperazine into ethanol, heating to react, cooling to crystallize, filtering, and purifying by a silica gel column to obtain the probe NIML.
Further preferably, the reaction temperature of the preparation process of the intermediate 1 is 70-90 ℃, the reaction time is 4-6h, and the organic solvent adopted by recrystallization is one or more of methanol, ethanol, isopropanol and ethyl acetate.
Further preferably, the reaction temperature of the preparation process of the intermediate 2 is 110-130 ℃ and the reaction time is 5-8h. The organic solvent used for recrystallization is one or more of methanol, ethanol, isopropanol and ethyl acetate. 5. The method for preparing a fluorescent probe according to claim 2, wherein the reaction temperature of the preparation process of the intermediate 3 is 110-130 ℃, the reaction time is 15-20h, and the organic solvent is one of dichloromethane and DMF.
Further preferably, the reaction temperature of the preparation process of the probe NIML is 75-85 ℃ and the reaction time is 5-6h.
The invention also discloses application of the fluorescence probe for detecting peroxynitroso anions in cell imaging visualization. In particular, the cell imaging is apoptosis imaging, cell activity imaging and cytotoxicity imaging, and the main reasons that the fluorescent probe can be used for cell imaging are that the fluorescent probe can detect the change of ONOO-concentration in cells, and the detection sensitivity and the detection limit are only 50 mu M. Meanwhile, the fluorescent probe has positive response to intracellular viscosity and RNA.
The invention has the beneficial effects that:
(1) The fluorescence probe NIML can detect the change of the concentration of the ONOO in a ratio, the detection limit is low, and the concentration of the ONOO saturation reaction is only 50 mu M.
(2) The response time is short, the reaction can be completed in about three minutes, and the response capability is good.
(3) The probe NIML has good response effects on viscosity and RNA.
(4) The probe NIML can well detect the apoptosis process.
(5) The fluorescent probe has simple preparation method and low preparation cost.
Drawings
FIG. 1 is a diagram of the compound NIML 1 H NMR spectrum;
FIG. 2 is a diagram of the compound NIML 13 C NMR spectrum;
FIG. 3 is a chart of a probe NIML spectral test;
(A) 10 mu M NIML for ONOO - Is a graph of the absorption spectrum of (2); (B) 10 mu M NIML under 450nm excitation, as for ONOO - Is a fluorescence spectrum of (2); (C, D) 10. Mu.M NIML at 450nm excitationAbout 50 μm ONOO - Is a dynamic fluorescence spectrum of (1);
FIG. 4 shows the NIML viscosity, RNA concentration titration ultraviolet and fluorescence spectroscopy,
(A) Fluorescence spectra of 10 μm NIML in mixed solutions of methanol and glycerol at different ratios under excitation at 450 nm; (B) absorbance spectra of 10 μm NIML with respect to RNA titration concentration; (C) Fluorescence spectra for RNA titration concentration at 450nm excitation with 10 μm NIML;
FIG. 5 is a fluorescence image of living cells incubated with NIML and MTDR for 30 minutes;
FIG. 6 is an image of fixed cells incubated with NIML for 30 minutes and fixed cells treated with DNase or RNase;
FIG. 7 is a fluorescent image of probe NIML in fixed cells and in fixed cells treated with 500. Mu.M ONOO.
Detailed Description
The present invention will be further described with reference to examples for the purpose of making the objects and technical aspects of the present invention more apparent, but the scope of the present invention is not limited to these examples, which are only for explaining the present invention. It will be understood by those skilled in the art that variations or equivalent substitutions that do not depart from the spirit of the invention are intended to be included within the scope of the invention. The present invention is further described below with reference to examples, but the present invention is not limited to the examples.
The medicines used in the invention are purchased from outsourcing, and 4-bromo-1, 8-naphthalene anhydride is purchased from Shanghai Honghao biological medicine technology Co., ltd; n, N-dimethylethylenediamine and 4-fluorobenzaldehyde are purchased from Shanghai Jizhui Biochemical technologies Co., ltd; piperazine was purchased from Shanghai national medicine control chemical reagent Co., ltd; 2, 3-trimethyl-3H-indole was purchased from Anhui Zernike technologies Co., ltd; methyl iodide was purchased from the scientific and technological company of belgium. Reagents required for biological imaging: mitochondrial deep red is purchased from molecular probes, inc; DNA and RNA were purchased from Sigma Aldrich trade Co., ltd (project number: DNA is D1501, RNA is R6625), which are natural DNA and RNA isolated from calf thymus and yeast.
The specific manufacturers of the organic synthesis instrument are as follows: magnetic stirrers, oil baths, and vacuum pumps (R5614Y-1) were purchased from the company of the instrument limited, incorporated; rotary evaporator (N-1100) was purchased from tokyo physicochemical company; electronic balance (LE 204E/02) purchased from Metler Shanghai Co., ltd; biological imaging instrument: nikon A1MP confocal microscope was purchased from Nikon corporation; carbon dioxide incubators are purchased from pine appliances limited.
Example 1:
synthesis of intermediate 1: 4-bromo-1, 8-naphthalene anhydride (7 mmol) was added to the reaction flask, dissolved in a small amount of ethanol solvent, and N, N-dimethylethylenediamine (21 mmol) was added thereto, dissolved in a large amount of ethanol solvent, and the mixed solution was refluxed for 4 hours and cooled to room temperature. The precipitate was separated out and filtered to give a crude product which was recrystallized from ethanol to give a solid with 86% yield.
Synthesis of intermediate 2: piperazine (17.4 mmol) was added to a reaction flask containing 25mL of methoxyethanol and 18mL of water, and after stirring at room temperature for 15 minutes, a mixed solution containing 5mL of water and 4-fluorobenzaldehyde (4.64 mmol) was slowly dropped into the reaction flask. The mixture was stirred and refluxed for 24 hours, cooled and then taken up in CH 2 Cl 2 Extracting. At Na (Na) 2 SO 4 After the organic layer was dried, the solvent was removed by evaporation. The yellow product was obtained after recrystallisation from ethanol in 67% yield.
Synthesis of intermediate 3: in a reaction flask, compound 1 (10 mmol) and Compound 2 (10 mmol) were added, and the mixture was refluxed with ethylene glycol monomethyl ether for 24 hours and cooled with CH 2 Cl 2 Extracting, removing the solvent by evaporation, using CH 2 Cl 2 /CH 3 The crude product was purified by chromatography on silica gel using an OH mixture (from 35:1 to 30:1, v/v) as eluent to give a yellow solid in 62% yield.
Synthesis of intermediate 4: 2, 3-trimethyl-3H-indole (5 mmol) was added to a reaction flask, dissolved with a small amount of ethanol solvent, methyl iodide (10 mmol) was added to the flask, dissolved with 2ml of ethanol solvent, heated to reflux for 9 hours, then solid was precipitated in the solution, the mixed solution was cooled to room temperature, filtered and washed with petroleum ether and ethanol several times to give a reddish-purple product with a yield of 85%.
Synthesis of probe NIML: to a reaction flask charged with compound 3 (13 mmol) and compound 4 (13 mmol) was added ethanol (3 mL) and stirred for 10 min, followed by several drops of piperidine. Reacting at 85deg.C for 12h, cooling to room temperature, removing solvent by evaporation, using CH 2 Cl 2 /CH 3 The crude product was purified by chromatography on silica gel with an OH mixture (from 15:1 to 10:1, v/v) as eluent to give a red solid in 65% yield. 1 H NMR(400MHz,DMSO-d 6 )δ8.60(d,J=8.5Hz,1H),8.53(d,J=7.2Hz,1H),8.46(d,J=8.0Hz,1H),8.35(d,J=15.8Hz,1H),8.16(d,J=8.7Hz,2H),7.88(t,J=7.9Hz,1H),7.82(d,J=7.3Hz,1H),7.77(d,J=7.9Hz,1H),7.59(t,J=7.6Hz,1H),7.53(t,J=7.4Hz,1H),7.47–7.35(m,2H),7.23(d,J=8.8Hz,2H),4.18(t,J=6.8Hz,2H),4.04(s,3H),3.88(d,J=5.8Hz,4H),3.43(d,J=5.6Hz,4H),3.38(t,J=6.8Hz,2H),2.27(s,6H),1.78(s,6H).
13 C NMR(151MHz,DMSO-d 6 ) Delta 180.81,164.26,163.71,155.69,154.72,154.14,143.31,142.45,132.76,131.35,131.18,129.69,129.26,128.56,126.72,125.75,124.44,123.14,123.10,122.78,116.38,115.77,114.50,114.23,114.02,107.49,55.36,52.60,51.69,47.03,46.79,44.93,33.89,26.47 nuclear magnetic hydrogen spectrum and carbon spectrum are shown in figure 1 and figure 2.
Example 2: probe NIML spectroscopic testing
Preparing a probe mother solution: 3.7mg of probe was weighed and dissolved in 1mL of DMSO to prepare a 5mM stock solution.
Preparation of sodium bisulfite: 10.4mg of sodium bisulphite was weighed out and dissolved in 10mL of deionized water to prepare a 10mM solution.
ONOO - Is prepared from the following steps: under ice bath condition, stirring vigorously to contain NaNO 2 HCl (0.6M, 10 mL) was added to a mixture of (0.6M, 10 mL) and hydrogen peroxide (0.7M, 10 mL), followed by rapid addition of sodium hydroxide (1.5M, 20 mL). Finally, a very small amount of manganese dioxide was added and filtered. Note that the solutions described above were all prepared from deionized water, and that ONOO was prepared - It should be preserved at-20deg.C in dark place. ONOO (oxide-nitride-oxide) - And (3) concentration calibration: firstly, use2mL of 0.1M sodium hydroxide was scanned across the baseline, and X. Mu.L of prepared ONOO was added to the V mL of 0.1M sodium hydroxide - Solutions were subjected to UV measurements, calculated as follows, wherein A 302 nm Is ONOO - Absorbance at 302nm, V is total volume of solution, X is ONOO - Volume of solution.
With respect to ONOO - Is characterized by comprising the following steps of: firstly preparing a blank, adding 4 mu L of 5mM probe solution into 2mL of mixed solution of PBS buffer solution and ethanol (volume ratio is 1 to 1), wherein the working concentration of the probe is 10 mu M, and then adding ONOO with a certain concentration - The solution was subjected to ultraviolet or fluorescence spectroscopic testing. (excitation wavelength in fluorescence Spectrum test is 450 nm)
Method for measuring absorption and fluorescence spectrum of sodium bisulphite: a blank sample is prepared, 4 mu L of a probe solution with the concentration of 5mM is added into 2mL of a mixed solution of PBS buffer solution and ethanol (the volume ratio is 1 to 1), the working concentration of the probe is 10 mu M, and then a sodium bisulphite solution with a certain concentration is added for ultraviolet or fluorescence spectrum test. (excitation wavelength in fluorescence Spectrum test is 450 nm)
Fluorescence spectrum test method for viscosity: mixed solutions of glycerol and methanol with different volume ratios are prepared, and 2 mu L of NIML probe with the concentration of 5mM and NIML probe solution are respectively added into 2mL of the mixed solution with different proportions, so that fluorescence spectrum test can be carried out. (excitation wavelength in fluorescence Spectrum test is 450 nm)
Fluorescence spectrum test method for RNA and DNA: mu.L of NIML probe and NIML probe solution with concentration of 5mM are respectively added into 2mL of PBS buffer solution, and then a certain amount of DNA and RNA solution are respectively added for fluorescence spectrum test. (excitation wavelength 450nm in fluorescence spectroscopy test) DNA and RNA molar concentration determination: DNA and RNA solutions were initially prepared at a concentration of 1mg/mL, and a portion of the stock was diluted in order to quantify their molar concentration. The DNA solution was diluted 200-fold and the RNA solution was diluted 250-fold. The absorbance spectra of the diluted DNA, RNA solutions were then measured.
Regarding the selective absorption, fluorescence spectrum test method:
cysteine, glutathione, glycine, serine, proline, alanine, glutamic acid, threonine, histidine, valine, asparagine, phenylalanine, arginine, glucose, sucrose, sodium chloride, potassium nitrate, hydrogen peroxide and VC (working concentration is 50 mu M) are selected as interference substances to be detected, and the analysis substances are weighed and dissolved by deionized water. mu.L of a 5mM probe solution was added to 2mL of a mixed solution of PBS buffer and ethanol (volume ratio: 1 to 1), and the above interfering substances were added to each solution, respectively, to perform ultraviolet or fluorescence spectroscopic measurement. (excitation wavelength in fluorescence Spectrum test is 450 nm)
(1) ONOO-concentration titration ultraviolet spectroscopy test:
first, the probe pair ONOO is performed - Is measured by concentration titration ultraviolet. As shown in FIG. 3A, no ONOO is added - When the absorption peak appears in the range of 450nm and 600 nm; with the continuous addition of ONOO - (0-5 eq) where the absorption peak was changed, was continuously decreased, and another absorption peak was gradually appeared in the range of 350nm and 450nm, and had a tendency to be increased. The UV spectrum test results indicated that the probe was responsive to ONOO-.
(2) ONOO-concentration titration fluorescence spectroscopy test
ONOO of probes - As shown in fig. 3B. Similar to the above ultraviolet test results, the emission peak of the blank probe solution was around 608nm under 450nm excitation; ONOO when added to solution - At higher and higher concentrations (0-5 eq), the fluorescence intensity of the probe at this point correspondingly decreases and an emission peak appears around 545nm, which peak increases continuously; when ONOO is formed - When 5 equivalents were added, the fluorescence intensity at 545nm reached a maximum. The fluorescence spectrum test results show that the probe and the ONOO - The reaction is continuously carried out andthere will be a major material formation.
(3) ONOO-kinetic Spectrometry test
To further understand the probe pair ONOO - Dynamic testing was performed in response to the conditions of the test. As shown in FIG. 3C, when 5 equivalents of ONOO are added under 450nm excitation - At this time, the fluorescence intensity of the probe at 608nm was drastically reduced, the emission peak at 545nm was rapidly developed, and the peak was rapidly reached. As is clearly shown in FIG. 3D, this process is performed with the probe pair ONOO - Only about 3 minutes is required for the response time of (c). The test results show that it is specific to ONOO - The response is quicker.
(4) Viscosity fluorescence Spectrometry test
Probe NIML is viscosity responsive due to limited rotation within the molecule. Fluorescence spectroscopy of the viscosity system was performed on probe NIML. Mixed solutions of methanol and glycerin in different ratios were used as viscosity test systems. The more glycerol content means the greater the viscosity of the whole mixed solution. As shown in FIG. 4A, the greater the ambient viscosity at which the probe is exposed to excitation at 450nm, the greater the fluorescence intensity. When the viscosity is 0.6cp, the fluorescence of the probe at 611nm is very weak; when the viscosity was increased to 945.3cp, the fluorescence of the probe at this point was significantly enhanced, increasing the fluorescence intensity from 139.4 to 4248 by nearly 30-fold. The above results indicate that the probe responds well to viscosity.
(6) RNA concentration titration ultraviolet and fluorescence spectrum test
From previous measurements of the probe's emission spectrum with respect to viscosity, it was determined that the probe has a certain response to viscosity, and that the probe will generally have a certain affinity for RNA since RNA will also provide an environment similar to viscosity such that intramolecular rotation of the probe is limited. To verify the above hypothesis, spectroscopic testing of the probe with respect to RNA was performed. First, the ultraviolet spectrum test, as shown in FIG. 4B, shows that the absorbance peak slightly shifted when 80 equivalents of RNA were added. As shown in FIG. 4C, the fluorescence of the blank probe solution at 605nm is weak under 450nm excitation; the fluorescence intensity gradually increases as the concentration of added RNA increases; the fluorescence intensity was maximized until 80 equivalents of RNA were added. The results of the two spectrum experiments show that the probe has stronger binding capacity to RNA.
Example 3: cell imaging experiments
Co-localization experiments Using the commercial probe MitoTracker Deep-Red (MTDR) as a co-localization reagent, cell images were obtained under a Nikon A1MP confocal microscope after incubation of cells for half an hour with 2. Mu.M NIML and 50nM MTDR. The fluorescence signal of NIML is collected in the red channel (570-620 nm,561nm excitation), while the emission signal of MTDR is collected in the deep red channel (665-730 nm,647nm excitation). Firstly, living cells and co-localization imaging experiments are carried out, as shown in fig. 5, the probe is expressed in a filiform form in a green channel fluorescent signal, the staining position of the probe is presumed to be mitochondria, then the probe and MTDR are stained together, and a green channel fluorescent image and a red channel fluorescent image are well overlapped.
The cell immobilization experiment and the RNA hydrolase and DNA hydrolase experiment steps are as follows: cells were treated with 4% paraformaldehyde for 1 hour, washed with PBS, and then treated with 0.5% Triton X-100 for 30 minutes to give dead cells. The fixed cells were incubated with 2. Mu.M probe NIML for half an hour, and the fixed cell imaging experiment was observed under a confocal laser microscope. During the RNA hydrolase assay, the fixed cells were treated with 20. Mu.g/mL RNA hydrolase for two hours, then with 2. Mu.M NIML for 30 minutes, and then with Nikon A1MP confocal microscopy to obtain imaging assay data. In the DNA hydrolase test, 10 mu L of DNA hydrolase with the product specification of 1000u is added into dead cells and treated for half an hour, and then 2 mu M of NIML is used for incubation for 30 minutes, so that fluorescent signals of the probe in the cells can be collected under a microscope. Cells were imaged with red (collected at 570-620nm, excitation wavelength 561 nm) channels. In order to understand the staining and distribution of probe NIML in fixed cells, a related cell imaging experiment was performed. As shown in FIG. 6, in living cells, the probe emits strongly in the red channel, mainly distributed in the cytoplasm, and the fluorescent signal is expressed in a filiform form. In fixed cells, the fluorescent signal of the probe in the red channel is enhanced and distributed in the cytoplasm and nucleus. When the immobilized cells were treated with DNase, the fluorescent signal of the probe in the red channel was distributed in the cytoplasm and nucleolus, indicating that the probe was not bound to DNA. When the fixed cells were treated with RNase, red fluorescent signals were distributed in the nuclei, indicating binding of the probe to RNA.
ONOO-cell experiments fixed cells were used with 500 μm ONOO - After a period of treatment, the fluorescent signal of the probe in the cell can be collected under a microscope. Cells were imaged with two channels, green (500-550 nm for excitation wavelength 488 nm) and red (570-620 nm for excitation wavelength 561 nm). In order to understand the staining and distribution of probe NIML after ONOO treatment in fixed cells, a related cell imaging experiment was performed.
As shown in FIG. 7, in the absence of ONOO treatment, probe NIML produces a distinct fluorescent signal in the red channel, which is localized in the nucleus; when cells were treated with ONOO-, the fluorescent signal of the probe in the red channel was significantly reduced and barely detectable; while generating a distinct fluorescent signal in the green channel. The results show that the probe added ONOO in the immobilized cells - And then has a good response.
Claims (10)
1. A fluorescent probe for detecting peroxynitroso anions, code NIML, characterized in that the fluorescent probe has the following structure:
2. a method for preparing a fluorescent probe for detecting peroxynitroso anions according to claim 1, wherein the preparation method comprises the steps of:
preparation of intermediate 1: adding 4-bromo-1, 8-naphthalene anhydride and N, N-dimethyl ethylenediamine into ethanol, heating to react, cooling to separate out solid, filtering to obtain intermediate 1 crude product, and recrystallizing with organic solvent to obtain pure intermediate 1;
preparation of intermediate 2: adding piperazine and p-fluorobenzaldehyde into ethylene glycol monomethyl ether for heating reaction, cooling for crystallization, filtering, adding an organic solvent for recrystallization to obtain an intermediate 2;
preparation of intermediate 3: adding the intermediate 1 and the intermediate 2 into a reaction bottle, adding the reaction bottle into ethylene glycol monomethyl ether, heating for reaction, cooling, adding water and an organic solvent, layering, concentrating an organic phase to obtain a crude product of the intermediate 3, and purifying by a silica gel chromatographic column to obtain a pure intermediate 3;
preparation of intermediate 4: adding 2, 3-trimethyl-3H-indole and methyl iodide into a reaction bottle, adding ethanol, heating for reaction for 7-10 hours, cooling for crystallization, filtering and washing to obtain an intermediate 4;
preparation of probe NIML: adding the intermediate 3, the intermediate 4 and the piperazine into ethanol, heating to react, cooling to crystallize, filtering, and purifying by a silica gel column to obtain the probe NIML.
3. The method for preparing a fluorescent probe according to claim 2, wherein the reaction temperature of the preparation step of the intermediate 1 is 70-90 ℃, the reaction time is 4-6 hours, and the organic solvent used for recrystallization is one or more of methanol, ethanol, isopropanol and ethyl acetate.
4. The method for preparing a fluorescent probe according to claim 2, wherein the reaction temperature of the intermediate 2 is 110-130 ℃ and the reaction time is 5-8h. The organic solvent used for recrystallization is one or more of methanol, ethanol, isopropanol and ethyl acetate.
5. The method for preparing a fluorescent probe according to claim 2, wherein the reaction temperature of the intermediate 3 is 110-130 ℃ and the reaction time is 15-20h, and the organic solvent is one of dichloromethane and DMF.
6. The method of preparing a fluorescent probe according to claim 2, wherein the reaction temperature is 75-85 ℃ and the reaction time is 5-6h.
7. Use of a fluorescent probe for detecting peroxynitroso anions according to claim 1 in cell imaging visualization.
8. The use of cell imaging visualization of claim 7, wherein the cell imaging is apoptosis imaging, cell activity imaging, and cytotoxicity imaging.
9. The use of the cell imaging visualisation of claim 7, wherein the fluorescent probe is capable of detecting changes in ONOO-concentration in cells, wherein the ONOO-detection limit is 50 μm.
10. The use of cell imaging visualization of claim 7 wherein the fluorescent probe responds positively to intracellular viscosity, RNA.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310627342.5A CN116621814B (en) | 2023-05-31 | Fluorescent probe for detecting peroxynitroso anions, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310627342.5A CN116621814B (en) | 2023-05-31 | Fluorescent probe for detecting peroxynitroso anions, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116621814A true CN116621814A (en) | 2023-08-22 |
CN116621814B CN116621814B (en) | 2024-05-14 |
Family
ID=
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105001161A (en) * | 2015-06-08 | 2015-10-28 | 华中师范大学 | Sulfamide compound based on 1,8-naphthalimides as framework and preparation method and application thereof |
CN107652968A (en) * | 2017-11-06 | 2018-02-02 | 北京理工大学 | A kind of peroxidating nitrosyl fluorescence probe and its preparation method and application |
CN108129459A (en) * | 2018-01-10 | 2018-06-08 | 济南大学 | A kind of novel fluorescence probe and its application for being used to detect sulfur dioxide |
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105001161A (en) * | 2015-06-08 | 2015-10-28 | 华中师范大学 | Sulfamide compound based on 1,8-naphthalimides as framework and preparation method and application thereof |
CN107652968A (en) * | 2017-11-06 | 2018-02-02 | 北京理工大学 | A kind of peroxidating nitrosyl fluorescence probe and its preparation method and application |
CN108129459A (en) * | 2018-01-10 | 2018-06-08 | 济南大学 | A kind of novel fluorescence probe and its application for being used to detect sulfur dioxide |
Non-Patent Citations (3)
Title |
---|
GUOXU QIN等: ""Ultrathin Cd-3, 5-PDC nanosheets enhanced NAP fluorescence probe for visualized detection of peroxynitrite"", 《SENSORS ANDACTUATORS:B.CHEMICAL》, vol. 378, 10 December 2022 (2022-12-10), pages 133147 - 133153 * |
Q.-C. WANG等: ""New benzo[e]indolinium cyanine dyes with two different fluorescence wavelengths"", 《DYES AND PIGMENTS》, vol. 59, 31 December 2003 (2003-12-31), pages 163 - 172, XP004452631, DOI: 10.1016/S0143-7208(03)00105-0 * |
X. KONG等: ""Simultaneously imaging of SO2 in lysosomes and mitochondria based on a dual organelle-targeted fluorescent probe"", 《SENSORS & ACTUATORS: B. CHEMICAL》, vol. 292, 18 April 2019 (2019-04-18), pages 80 - 87, XP085683798, DOI: 10.1016/j.snb.2019.04.094 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111423423B (en) | Application of ratiometric fluorescent probe in detecting peroxynitrite anion | |
CN109081836B (en) | Mercury ion near-infrared fluorescent probe based on hemicyanine structure and preparation method and application thereof | |
Peng et al. | A novel fluorescent probe for selective detection of hydrogen sulfide in living cells | |
CN107056769A (en) | A kind of L cysteines fluorescence probe and preparation method thereof | |
CN108398409B (en) | Method for detecting hypochlorite by fluorescence ratio | |
CN113135948B (en) | For detecting ClO-/ONOO-Ratiometric fluorescent probes, methods of making and uses thereof | |
CN109336815B (en) | Two-photon fluorescent probe for detecting hypochlorous acid in intracellular endoplasmic reticulum | |
Resa et al. | New dual fluorescent probe for simultaneous biothiol and phosphate bioimaging | |
Zeng et al. | A near-infrared fluorescent sensor with large Stokes shift for rapid and highly selective detection of thiophenols in water samples and living cells | |
CN111518089B (en) | Ratio type fluorescent probe for detecting pH, and preparation method and application thereof | |
CN110229165A (en) | Up-conversion fluorescence probe Rhodamine Derivatives and its application | |
Jothi et al. | A new sensitive “turn-on” fluorescent probe based on naphthalimide: Application in visual recognition of hydrogen sulfide in environmental samples and living cells | |
Chen et al. | A pyrene-based ratiometric fluorescent probe with a large Stokes shift for selective detection of hydrogen peroxide in living cells | |
CN111004246B (en) | Rhodamine pH fluorescent probe for monitoring mitochondrial autophagy, preparation and application thereof | |
CN113292582A (en) | Synthesis and application of bifunctional fluorescent probe capable of distinguishing hydroxyl free radicals and hydrogen peroxide simultaneously | |
CN107286173B (en) | Rhodol derivative and preparation method and application thereof | |
CN108752373B (en) | Fluorescent probe for identifying hydrogen peroxide based on phenylboronate | |
CN106608862A (en) | Long-wavelength fluorescent probe for detecting hydrazine and synthetic method and application of long-wavelength fluorescent probe | |
CN113956274A (en) | Design and synthesis method of fluorescent probe capable of responding to viscosity and peroxynitrite change in epileptic diseases | |
CN110357896B (en) | Compound, preparation and application thereof in detecting divalent copper ions and strong acid pH | |
CN111233928B (en) | Coumarin derivative Mito-Cys and preparation method and application thereof | |
CN116621814B (en) | Fluorescent probe for detecting peroxynitroso anions, preparation method and application thereof | |
CN114874188B (en) | Lipid-droplet fluorescent probe containing carbazole-pyridine formylhydrazine group and preparation method and application thereof | |
CN114106024B (en) | Fluorescent probe and preparation method and application thereof | |
CN114276356B (en) | Mitochondria-targeted fluorescent probe and synthesis method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |